4.5 (476) In stock
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a
CD56 Antibody, anti-human, REAfinity™
PHD1 regulates p53‐mediated colorectal cancer chemoresistance
A 3D primary human cell-based in vitro model of non-alcoholic
T cell immunotherapy for cardiac fibrosis: mRNA starts the CAR
Investigating fibrosis and inflammation in an ex vivo NASH murine
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated
Targeting CD301+ macrophages inhibits endometrial fibrosis and
Mouse Monoclonal Anti-CD45 Antibody (MEM-28). Tested Applications: Western Blot, Flow Cytometry, ICC, IHC, IHC-Paraffin, IP. Tested Reactivity: Human.
CD45 Antibody (MEM-28) - BSA Free (NB500-319): Novus Biologicals
US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5